An Update and possible (and we think exciting) patient-driven solution.
June 7, 2019

The latest developments on the iCancer clinical trial and an exciting new idea
Read moreThe latest developments on the iCancer clinical trial and an exciting new idea
Read moreUpdate on the AdVince (iCancer) trial at Uppsala University.
Read moreBased on the iCancer model we are proposing a new approach to funding clinical trials.
Read moreIf mega-rich people could buy places on clinical trials, would this help drive forward the development of new treatments that could benefit everyone? Alexander Masters thinks it might just work.
Read moreThanks to YOU - the crowd - the iCancer clinical trial begins in Sweden
Read moreWe've done it
Read moreRunning for iCancer
Read moreA huge thank you to everybody who has donated
Read moreA round-up of phenomenal press coverage
Read moreAlexander Masters talks about why there is no funding for this anti-cancer virus and why big business will not invest.
Read moreIndependent analysis of iCancer
Read moreVirus creator Prof Justyna Leja on the creation of the anti-cancer virus
Read moreAn author is launching a 'crowd-funding’ campaign to pay for vital research
Read moreTwo weeks ago, Dominic Nutt read in the Telegraph about a possible cure for his rare cancer. But without funding – a paltry £2 million – it can’t go to trial. So, he asks, what price a life?.
Read moreA British author whose friend is slowly dying of the same cancer that killed Steve Jobs, has appealed to Apple to help fund development of a potential treatment that could have saved the billionaire.
Read moreSitting in a refrigerator in a Swedish laboratory is what promises to be a cheap and effective cancer treatment. So why are the trials to bring it to market not going ahead?
Read more